Gurizzan C - Search Results

1

Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.

Roca E, Gurizzan C, Amoroso V, Vermi W, Ferrari V, Berruti A. Roca E, et al. Among authors: gurizzan c. Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31. Cancer Treat Rev. 2017. PMID: 28806542 Review.

2

High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases.

Laganà M, Gurizzan C, Roca E, Cortinovis D, Signorelli D, Pagani F, Bettini A, Bonomi L, Rinaldi S, Berardi R, Filetti M, Giusti R, Pilotto S, Milella M, Intagliata S, Baggi A, Cortellini A, Soto Parra H, Brighenti M, Petrelli F, Bennati C, Bidoli P, Garassino MC, Berruti A. Laganà M, et al. Among authors: gurizzan c. Front Oncol. 2020 Nov 12;10:588862. doi: 10.3389/fonc.2020.588862. eCollection 2020. Front Oncol. 2020. PMID: 33282740 Free PMC article.

3

Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study.

Gurizzan C, Roca E, Faggiano A, Paoli D, Dinatolo E, Masini G, Tomasi C, De Palma G, Metra M, Berruti A, Faggiano P. Gurizzan C, et al. J Cardiovasc Med (Hagerstown). 2021 Jun 1;22(6):444-452. doi: 10.2459/JCM.0000000000001124. J Cardiovasc Med (Hagerstown). 2021. PMID: 33315692

4

Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.

Gurizzan C, Zamparini M, Volante M, Tovazzi V, Amoroso V, Consoli F, Petrelli F, Grisanti S, Bossi P, Berruti A. Gurizzan C, et al. Endocr Relat Cancer. 2021 Jul 5;28(8):593-604. doi: 10.1530/ERC-21-0123. Endocr Relat Cancer. 2021. PMID: 34105516

5

Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy.

Pedersini R, di Mauro P, Bosio S, Zanini B, Zanini A, Amoroso V, Turla A, Vassalli L, Ardine M, Monteverdi S, Zamparini M, Gurizzan C, Cosentini D, Ricci C, Simoncini EL, Berruti A. Pedersini R, et al. Among authors: gurizzan c. Sci Rep. 2021 Jun 21;11(1):12975. doi: 10.1038/s41598-021-92138-7. Sci Rep. 2021. PMID: 34155246 Free PMC article.

6

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic.

Gurizzan C, Pedersini R, Fornaro C, Sardini C, Zamparini M, Monteverdi S, Tovazzi V, Cosentini D, Dalla Volta A, Baggi A, Turla A, Di Mauro P, Lorini L, Laganà M, Bianchi S, Grisanti S, Consoli F, Conti E, Bossi P, Berruti A. Gurizzan C, et al. Front Oncol. 2021 Oct 14;11:707346. doi: 10.3389/fonc.2021.707346. eCollection 2021. Front Oncol. 2021. PMID: 34722252 Free PMC article.

7

Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.

Lombardi D, Tomasoni M, Lorini L, Gurizzan C, Tomasini D, Ardighieri L, Battocchio S, Bozzola A, Mattavelli D, Paderno A, Zamparini M, Farina D, Ravanelli M, Maroldi R, Maddalo M, Magrini S, Berruti A, Deganello A, Nicolai P, Bossi P, Piazza C. Lombardi D, et al. Among authors: gurizzan c. Oral Oncol. 2022 Mar;126:105764. doi: 10.1016/j.oraloncology.2022.105764. Epub 2022 Feb 11. Oral Oncol. 2022. PMID: 35158286

8

Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study.

Savarese T, Abate A, Basnet RM, Lorini L, Gurizzan C, Tomasoni M, Lombardi D, Tomasini D, Zizioli D, Memo M, Berruti A, Bonini SA, Sigala S, Bossi P. Savarese T, et al. Among authors: gurizzan c. Sci Rep. 2022 Jun 15;12(1):9951. doi: 10.1038/s41598-022-14197-8. Sci Rep. 2022. PMID: 35705678 Free PMC article.

9

Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis.

Petrelli F, Nardone M, Trevisan F, Carioli D, Falasca V, De Stefani A, Capriotti V, Gurizzan C, Lorini L, Berruti A, Luciani A, Bossi P. Petrelli F, et al. Among authors: gurizzan c. Eur Arch Otorhinolaryngol. 2023 Mar;280(3):963-971. doi: 10.1007/s00405-022-07710-2. Epub 2022 Oct 20. Eur Arch Otorhinolaryngol. 2023. PMID: 36261656 Review.

10

Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy.

Smussi D, Mattavelli D, Paderno A, Gurizzan C, Lorini L, Romani C, Bignotti E, Grammatica A, Ravanelli M, Bossi P. Smussi D, et al. Among authors: gurizzan c. Cancer Treat Rev. 2023 Dec;121:102644. doi: 10.1016/j.ctrv.2023.102644. Epub 2023 Oct 12. Cancer Treat Rev. 2023. PMID: 37862833 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters